These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29867487)

  • 1. Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR).
    Saeed MEM; Mahmoud N; Sugimoto Y; Efferth T; Abdel-Aziz H
    Front Pharmacol; 2018; 9():481. PubMed ID: 29867487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lignan, (-)-sesamin reveals cytotoxicity toward cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance.
    Saeed M; Khalid H; Sugimoto Y; Efferth T
    Phytomedicine; 2014 Apr; 21(5):689-96. PubMed ID: 24556122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
    J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
    Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
    Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine.
    Saeed MEM; Mahmoud N; Sugimoto Y; Efferth T; Abdel-Aziz H
    Front Pharmacol; 2018; 9():136. PubMed ID: 29535628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression.
    Saeed MEM; Rahama M; Kuete V; Dawood M; Elbadawi M; Sugimoto Y; Efferth T
    Phytomedicine; 2019 Jun; 59():152890. PubMed ID: 30921566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells.
    Abdelfatah SA; Efferth T
    Phytomedicine; 2015 Feb; 22(2):308-18. PubMed ID: 25765838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic Characterization of Cytotoxic Compounds from Salvia officinalis in Cancer Cells.
    Kadioglu O; Efferth T
    J Nat Prod; 2015 Apr; 78(4):762-75. PubMed ID: 25713926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of South-African medicinal plants towards sensitive and multidrug-resistant cancer cells.
    Saeed MEM; Meyer M; Hussein A; Efferth T
    J Ethnopharmacol; 2016 Jun; 186():209-223. PubMed ID: 27058630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing of Bromocriptine for Cancer Therapy.
    Seo EJ; Sugimoto Y; Greten HJ; Efferth T
    Front Pharmacol; 2018; 9():1030. PubMed ID: 30349477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.
    Mahmoud N; Saeed MEM; Sugimoto Y; Klauck SM; Greten HJ; Efferth T
    Oncotarget; 2018 Nov; 9(87):35762-35779. PubMed ID: 30515268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells.
    Saeed ME; Abdelgadir H; Sugimoto Y; Khalid HE; Efferth T
    J Ethnopharmacol; 2015 Nov; 174():644-58. PubMed ID: 26165828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.
    Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Teng QX; Chen ZS; Kong D; Yang DH
    Front Pharmacol; 2018; 9():1236. PubMed ID: 30425643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.